Abstract:

The process of drug discovery is lengthy and tortuous, spanning several years. These years are characterized by different stages of differing development processes. A major stage in this development process is the preclinical stage, which is characterized by testing the drug candidate in animal models as a predictor of its efficacy and tolerability in humans. Preclinical drug trial is froth with challenges, which range from choice of the appropriate animal species to generation of the relevant data for filling application for IND.

References:

[1.] Curry, A.., Brown, R. (2003). The target product profile as a planning tool in drug discovery research. Pharmatech, 67 – 71.

[2.] Foster, F.S., Mehi, J., Lukacs, M., Hirson, D., White, C., Chargares, C, et al.(2009) A new 15 – 50mHz array-based micro-ultrasound scanner for preclinical imaging. Ultrasound Medical Biology, 5(10): 1700-8.

[3.] Fox, S., Farr-Jones, S., Sopchak , L., Bogg, A., Nicely A.W., Houry, R.(2006) . High throughput screening; update on practices and successes. J Biol Sreen, 11,864-869.

[4.] Hughes, P.P., Rees, S., Kalindjian, S.B. & Philpott, K.L.(2011), Principles of early drug discovery. Br. J Pharmacology, 162(6) , 1239-1249.

[5.] Janghui, X., Jaun, L., Simon ,R., Ze ,T., Yinghui, L., Shanguang, C. (2010) Preclinical Drug Prioritization via Prognosis. Guided Genetic interaction Networks. PLoS One; 5(11): e13937. Doi:10.1371/journal.pone.0013937.

[6.] Kamb ,A.(2005). What’s wrong with our cancer models? Nat Rev Drug Discov.; 4: 161-165. doi: 10.1038/nrd 1635

[7.] Kareen L,S & Edward, G.S. (2009) .BMC Neurology Volume 9, Supplement 1, 2009: Proceeding of the 2009 Drug Discovery for Neurodegeneration conference. http://www.biomedcentral.com/147- 2377/9:?issue=S1 Accessed June 20.2012.

[8.] Kareen, L.S, & Edward, G. S. (2009). The basics of pre-clinical drug development for neurodegenerative disease indications. BMC Neurology; 9 (suppl I): 52 http://www.biomedcentre.com/1471 - 2377/9/51/52 (Website).

[9.] Network CGAR. (2008).Comprehensive genomic characterization, defines human glioblastoma genes and core pathways. Nature; 455:1061-1068. Doi.10.1038/nature 11903.CrossRef. PubMed/NCBI. Google Scholar. Accessed June 15,2012.

[10.]   Pacific biolabs (2012). Drug Development process; stages of drug development; http://www.pacificbiolabs.com/drug-stages-asp (website). 94;547 –San franscisco Bay Area. Retrieved June 15,2012..

[11.]   Pharmaceutical product development Inc. (2012), About Drug discovery & Development. PPD Homepage; http://www.ppdi.com/about-ppd/drug-development.htm Retrieved June 20th 2012.

[12.]   Radloff, D.R., Renella, E.S., & Treadgill, D.W., (2008). Modelling cancer patient populations in mice: Complex genetic and environmental factors. Drug Discov Today Dis Models 2008; 4:83-88 doi:10.1016/j.ddmod.2007.06.004. CrossRef. PubMed/NCBI. Google Scholar.

[13.]   Steven ,M. P., Mytelka, D.S, Widdie, D. U., Persinger, C.C., Munos, B.H., Lindborg S.R, et al.(2010). How to Improve R&D Productivity; The Pharmaceutical Industry grand Challenge: Nature Review; Drug Discovery., 9(3) 203 – 214.

[14.]   Wikipedia; free Encyclopedia. (2012).Drug discovery. http://.en.wikipedia.org/wikidrug_discovery: Retrieved June 15, 2012.

[15.]   Wikipedia; free encyclopedia. (2012), Preclinical drug development. http://www.wikipedia.org/wiki/pre-clinical-development (website) Retrieved 30 May, 2012.

[16.]   Wikipedia; free encyclopedia (2012). Pre-clinical Imaging. http://en.wikepedia.org/wiki/preclinical imaging.[website] Retrieved June 12, 2012

[17.]   William, J.K., Van Bruggen, N., Dinkelbors, L.M., Gambher, S.S. (2008). Molecular imaging in drug development, Nat. Rev. Drug Discovery July 7; 591 – 607.